Publication: Rivaroxaban for the treatment of saphenous vein graft thrombosis
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Marmagkiolis, Konstantinos
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Thrombus formafigtion plays a significant role in disease of saphenous vein bypass grafts. Use of oral anticoagulants has not been tested in treatment of thrombotic occlusion of saphenous vein graft (SVG) disease. Here we describe the use of the novel oral anticoagulant rivaroxaban in the treatment of occlusive SVG disease with intraluminal thrombus, leading to successful recanalization. (C) 2016 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
Source
Publisher
Elsevier Doyma Sl
Citation
item.page.haspartof
Source
Revista Portuguesa De Cardiologia
item.page.ispartofseries
item.page.edition
DOI
10.1016/j.repc.2015.11.024
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A